Epigallocatechin-3-gallate (Egcg) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of akt pathway and epithelial–mesenchymal transition: Enhanced efficacy when combined with gemcitabine

Ran Wei, Natalia E. Cortez Penso, Robert M Hackman, Yuefei Wang, Gerardo G. Mackenzie

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Epigallocatechin-3-gallate (Egcg) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of akt pathway and epithelial–mesenchymal transition: Enhanced efficacy when combined with gemcitabine'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences